Commercialization of a proprietary Ga-68 PSMA-targeted drug for PET imaging in recurrent prostate cancer

Information

• Research Project
• 9916719

• ApplicationId

  9916719

• Core Project Number

  R44CA233140

• Full Project Number

  5R44CA233140-03

• Serial Number

  233140

• FOA Number

  PA-17-302

• Sub Project Id

• Project Start Date

  8/10/2018 - 6 years ago

• Project End Date

  4/30/2021 - 3 years ago

• Program Officer Name

  NARAYANAN, DEEPA

• Budget Start Date

  5/1/2020 - 4 years ago

• Budget End Date

  4/30/2021 - 3 years ago

• Fiscal Year

  2020

• Support Year

  03

• Suffix

• Award Notice Date

  4/9/2020 - 4 years ago

Organizations

• Five Eleven Pharma Inc.

IC Name

• Activity

  R44

• Administering IC

  CA

• Application Type

  5

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  248430

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  395

• Ed Inst. Type

• Funding ICs

  NCI:248430\

• Funding Mechanism

  SBIR-STTR RPGs

• Study Section

  ZRG1

• Study Section Name

  Special Emphasis Panel

• Organization Name

  FIVE ELEVEN PHARMA, INC.

• Organization Department

• Organization DUNS

  079609313

• Organization City

  PHILADELPHIA

• Organization State

  PA

• Organization Country

  UNITED STATES

• Organization Zip Code

  191043143

• Organization District

  UNITED STATES